These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 963964)

  • 1. [Evaluation of the anti-hypertensive effect of spironolactone: trial of combined therapy with spironolactone and alpha-methyldopa].
    Cagli V
    Clin Ter; 1976 Feb; 76(3):253-60. PubMed ID: 963964
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative evaluation of aldactide and methyldopa in the management of benign essential hypertension.
    Nair KG; Jairam HN; Lal HM; Phaterpekar SJ
    J Assoc Physicians India; 1980; 28(1-2):7-13. PubMed ID: 7216969
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of alpha methyldopa and spironolactone on angiotensin sensitivity in man].
    Káldor A; Kállay K; Sebestyén K; Alexits K
    Orv Hetil; 1972 Jan; 113(1):23-4. PubMed ID: 4333395
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hypertensive states with a combination of alpha-methyldopa and a diuretic].
    Beretta R; Cassi E; Colombo A; De Paoli A; Marciandi C; Renzetti GA
    Clin Ter; 1982 Dec; 103(5):487-500. PubMed ID: 7160141
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential effect of hypotensive drugs on renal and steroid hypertensive rats.
    Willard PW; Beckhelm GA
    Arch Int Pharmacodyn Ther; 1968 May; 173(1):11-5. PubMed ID: 5657813
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of essential and nephrogenic hypertension using alpha-methyldopa and alpha-methyldopa+hydrochlorothiazide. Comparative study].
    Sales EJ; Villa JJ; Mendez MA
    Prensa Med Argent; 1971 Jun; 58(14):741-8. PubMed ID: 5091433
    [No Abstract]   [Full Text] [Related]  

  • 7. Problems in therapy for the hypertensive patient.
    Kim KE; Onesti G; Swartz C
    Geriatrics; 1973 Mar; 28(3):122-8. PubMed ID: 4691600
    [No Abstract]   [Full Text] [Related]  

  • 8. The long-term effectiveness of methyldopa in hypertension.
    Okun R; Roth SE; Gordon A; Maxwell MH
    Calif Med; 1966 Jan; 104(1):46-50. PubMed ID: 5909253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between spironolactone and hydrochlorothiazide with and without alpha-methyldopa in the treatment of hypertension.
    Walter NM; Suthers MB; Friedman A; Johnston CI
    Med J Aust; 1978 May; 1(9):509-12. PubMed ID: 353458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative human studies of a new anti-hypertensive drug (2,6-dichloro-benzylidene-aminoguanidine acetate) and methyldopa in hypertensive patients].
    Baldrighi V; Baldrighi G; Ronzoni L; Aiazzi L; Caprioli G
    Arch Sci Med (Torino); 1977; 134(2):185-92. PubMed ID: 869702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of arterial hypertension with alpha-methyldopa].
    Herteanu H; Bucur V
    Med Interna (Bucur); 1969 Sep; 21(9):1119-26. PubMed ID: 5378243
    [No Abstract]   [Full Text] [Related]  

  • 12. The combined use of L-alpha-methyldopa hydrazine and methyldopa in the treatment of hypertension.
    Louis WJ; Vajda FJ; McNeil JJ; Doyle AE; Jarrott B
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():17-22. PubMed ID: 354826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of hypertensive patients with alphamethyldopa].
    Trezzini C; Splendori F
    Clin Ter; 1970 Feb; 52(3):259-66. PubMed ID: 5419245
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dopegyt (alpha-methyldopa) in arterial hypertension].
    Kedra M; Koziara Z
    Pol Tyg Lek; 1971 Jun; 26(25):963-5. PubMed ID: 5564519
    [No Abstract]   [Full Text] [Related]  

  • 15. [Variations of renin activity in hypertensive patients under aldactone therapy].
    Popov NG; Kiprov D; Astrug A; Dotschev D
    Med Welt; 1971 Jul; 22(29):1207-9. PubMed ID: 5566156
    [No Abstract]   [Full Text] [Related]  

  • 16. [Considerations on ambulatory therapy in a group of hypertensive patients].
    Repetto S; Rezzonico A; Gervasini N
    Minerva Med; 1969 Jun; 60(51):2550-4. PubMed ID: 5792420
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the antihypertensive action of methyldopa alone or in combination with hydrochlorothiazide].
    Mattar E; Cruz HM; Cruz J
    Rev Paul Med; 1971 Jul; 78(1):19-30. PubMed ID: 5164628
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative mass studies on alpha-methyldopa (Presinol), Sali-Presinol and Cyclazenine in hypertensives of various origin].
    Schubert R; Pasz T
    Verh Dtsch Ges Inn Med; 1965; 71():445-55. PubMed ID: 5339213
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of spironolactone (Aldactone) and methyldopa in low and normal renin hypertension.
    Solheim SB; Sundsfjord JA; Giezendanner L
    Acta Med Scand; 1975 Jun; 197(6):451-6. PubMed ID: 1098396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin unresponsiveness and the effects of oxprenolol, methyldopa and spironolactone in patients with essential hypertension.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):60-1. PubMed ID: 1071406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.